Wall Street ended Wednesday with big tech nursing a hangover, small caps stealing the limelight, and investors once again discovering that the yield curve has a better sense of drama than most streaming services.
Indexes: Big Tech Blinks, Small Caps Smirk
The Nasdaq…
U.S. stocks slipped modestly on Tuesday as Wall Street digested a cooler core inflation print, a heavy dose of bank earnings, and fresh tariff salvos from Washington, leaving the major indexes just a step back from record territory rather than in full…
Wall Street kicked off the week in an ebullient mood Monday, as major U.S. equity benchmarks climbed to fresh heights while gold and silver behaved like they had just discovered caffeine
Indexes: Bulls in Full Voice
The S&P 500 added roughly 0.2%–0.3%, extending last…
Wall Street closed the first full week of 2026 looking less like a Santa rally and more like a New Year’s rebalancing, as investors rotated briskly beneath mostly resilient headline indexes. The Dow (+2.3%) and small-cap Russell 2000 (+4.6%) outperformed, helped by…
US stocks finished Thursday with a split personality: the Dow marched confidently higher, small caps finally stole a headline, and Big Tech discovered that gravity still works, even in an AI bull market.
Major indexes
The Dow Jones Industrial Average added about 270 points, or .55%,…
The major U.S. equity benchmarks spent Wednesday doing their best impression of a tightrope act, wobbling on tariff angst and rate jitters but largely maintaining their lofty perch near record territory.
Indexes: Gravity Check, Not Freefall
The S&P 500 edged lower, slipping…
Wall Street closed Tuesday with a spring in its step and a raised eyebrow, as blue chips powered to fresh records while small caps joined the party. A looming Supreme Court ruling on President Trump’s tariffs, another shutdown deadline, and a packed…
GeoVax Labs (NASDAQ: GOVX) is heading into the 44th Annual J.P. Morgan Healthcare Conference week ("JPM2026") in San Francisco, CA Jan. 12-15 with the kind of narrative biotech investors typically like to hear: a differentiated platform, large funded trials lining up, and…
As the opening week of 2026 trading gathers steam, investors seem content to embrace risk—so long as the Fed stays predictable, Congress keeps the lights on, and oil, gold and bitcoin provide just enough drama to keep everyone awake at the morning…
All told, the first, abbreviated week of 2026 felt less like the start of a new market regime and more like a terse sequel: the same cast of AI heroes, EV skeptics, tariff subplots and Fed suspense, just with a new calendar…
